Saliladja, Sabriya T.
HRN: 23-34-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2023
AMPICILLIN 250MG (VIAL)
07/29/2023
08/04/2023
IVTT
160mg
Q12
TC Fecal Impaction
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes